Zobrazeno 1 - 10
of 40
pro vyhledávání: '"J A, Mailliard"'
Autor:
G. A. Croghan, J. A. Sloan, I. T. Croghan, P. Novotny, R. D. Hurt, W. L. DeKrey, D. J. Walsh, J. A. Mailliard, L. P. Ebbert, D. K. Swan, M. Wiesenfeld, R. Levitt, P. Stella, P. A. Johnson, L. K. Tschetter, C. Loprinzi
Publikováno v:
Nicotine & Tobacco Research. 5:181-187
This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavi
Autor:
J C, Buckner, P J, Schomberg, W L, McGinnis, T L, Cascino, B W, Scheithauer, J R, O'Fallon, R F, Morton, S A, Kuross, J A, Mailliard, A K, Hatfield, J T, Cole, P D, Steen, A M, Bernath
Publikováno v:
Cancer. 92(2)
The current study was conducted to determine whether the addition of interferon-alpha (IFN-alpha) to treatment with radiation therapy and carmustine (BCNU) improves time to disease progression or overall survival in patients with high-grade glioma.Pa
Autor:
P A, Burch, M, Block, G, Schroeder, J W, Kugler, D J, Sargent, T A, Braich, J A, Mailliard, J C, Michalak, A K, Hatfield, K, Wright, S A, Kuross
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(9)
There continues to be a need for new systemic approaches for the treatment of advanced pancreatic cancer. The purpose of this study was to compare the antitumor activity of the somatostatin analogue octreotide to 5-fluorouracil chemotherapy in a Phas
Autor:
J A, Bonner, J A, Sloan, K M, Rowland, G G, Klee, J W, Kugler, J A, Mailliard, M, Wiesenfeld, J E, Krook, A W, Maksymiuk, E G, Shaw, R S, Marks, E A, Perez
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(2)
The level of serum neuron-specific enolase (NSE) has been implicated as a prognostic factor for patients with small cell lung cancer (SCLC). A prospective evaluation was undertaken to assess the prognostic significance of pretreatment NSE and treatme
Autor:
E A, Perez, D W, Hillman, P J, Stella, J E, Krook, L C, Hartmann, T R, Fitch, A K, Hatfield, J A, Mailliard, S, Nair, C G, Kardinal, J N, Ingle
Publikováno v:
Cancer. 88(1)
This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m(2) by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic b
Autor:
J N, Ingle, V J, Suman, P A, Johnson, J E, Krook, J A, Mailliard, R H, Wheeler, C L, Loprinzi, E A, Perez, V C, Jordan, M, Dowsett
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(7)
The goals of this clinical trial involving postmenopausal women with metastatic breast cancer were to: (a) examine the effects of letrozole on tamoxifen (TAM) pharmacokinetics; (b) examine estrogen suppression in patients receiving TAM plus letrozole
Autor:
J N, Ingle, V J, Suman, C G, Kardinal, J E, Krook, J A, Mailliard, M H, Veeder, C L, Loprinzi, R J, Dalton, L C, Hartmann, C A, Conover, M N, Pollak
Publikováno v:
Cancer. 85(6)
Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lin
Autor:
J A, Bonner, W L, McGinnis, P J, Stella, R F, Marschke, J A, Sloan, E G, Shaw, J A, Mailliard, E T, Creagan, R K, Ahuja, P A, Johnson
Publikováno v:
Cancer. 82(6)
A three-arm Phase III randomized trial was performed to compare response rates, time to local or distant progression, and survival for patients with unresectable (Stage IIIA or IIIB) nonsmall cell lung carcinoma treated with standard fractionated tho
Autor:
J N, Ingle, P A, Johnson, V J, Suman, J B, Gerstner, J A, Mailliard, J K, Camoriano, D H, Gesme, C L, Loprinzi, A K, Hatfield, L C, Hartmann
Publikováno v:
Cancer. 80(2)
It is common practice to utilize a series of different hormonal agents in the treatment of postmenopausal women who, despite disease progression, continue to be candidates for hormonal therapy on a clinical basis. Letrozole is a new highly selective
Autor:
J, Rubin, J G, Gallagher, G, Schroeder, A J, Schutt, R J, Dalton, J W, Kugler, R F, Morton, J A, Mailliard, P A, Burch
Publikováno v:
Cancer. 78(9)
Previous trials in patients with colorectal carcinoma have indicated that enhancement of 5-fluorouracil (5-FU) by leucovorin (LV) can result in an improved response rate and increased survival.Phase II trials were performed with patients who had eith